Current Clinical Trials

Prostate Cancer Screening
Clinical study to collect and store subject samples to be used in the development and validation of diagnostic tests for the detection of prostate cancer.

The study is open to males who are scheduled for a prostate biopsy. Exclusion Criteria: 

•  Men who have had prostate biopsy within 30 days prior to collection

• Men currently or formerly who have undergone prostate cancer treatments including but not limited to prostatectomy, radiotherapy, or androgen deprivation

• Men who have been diagnosed with cancer of any kind, and are currently undergoing active treatment, except skin cancer

        

Stress Urinary Incontinence

You may be able to take part in the study if you are:

• Are a woman at least 18 years of age,

• Still experience urine leakage on effort or exertion, or on sneezing or coughing, at least 2 times a day after surgical treatment,

• Have tried pelvic floor muscle training (PFMT) and received a surgical treatment for SUI, which didn’t resolve your symptoms.

 

​

​

​

​

Bladder Cancer 
An open-label study to evaluate safety and anti-tumor activity of intravesical instillation of TARA-002 in adults with high-grade non-muscle invasive bladder cancer.

Participants with recent diagnosis of carcinoma in situ who have either failed BCG therapy or not able to obtain BCG therapy may be eligible.

 

​
 

​

​

Interstitial Cystitis/Bladder Pain Syndrome (IC)​

• Females 18-64 years old

• Diagnosis of IC greater than 6 months ago

• Experiencing frequency, pain, pressure, and/or discomfort

• Documentation of cystoscopy in the past 9 months 

 

​

​

Erectile Dysfunction

Heterosexual males 18 and over with diagnosed with erectile dysfunction for at least 6 months may be eligible.

​

​

​

​

​

Interstitial Cystitis

Males and females ages 18-75 yrs old diagnosed with interstitial cystitis for at least 6 months may qualify. 

​

​

​

​

Stress Urinary Incontinence

Females ages 18-55 diagnosed with stress urinary incontinence with no history of prior treatment may be eligible.

​

​

​

​

To see if you qualify for one of the above trials, please send us an email.